Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2020 | 04-2019 | 04-2018 | 04-2017 | 04-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 895 | 515 | 1,060 | 3,464 | 1,921 |
| TOTAL | $1,038 | $653 | $1,284 | $3,539 | $2,031 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 7 | 7 | 7 | 7 | 8 |
| TOTAL | $5,129 | $5,129 | $5,129 | $5,129 | $5,130 |
| Total Assets | $6,167 | $5,782 | $6,413 | $8,668 | $7,160 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29 | N/A | N/A | N/A | 150 |
| Accounts payable and accrued liabilities | 186 | 122 | 353 | 366 | 336 |
| Accrued Expenses | 817 | 621 | 292 | 215 | 152 |
| TOTAL | $1,031 | $743 | $644 | $580 | $638 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46 | N/A | N/A | N/A | N/A |
| TOTAL | $46 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,078 | $743 | $644 | $580 | $638 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,634 | 930 | 729 | 681 | 594 |
| Common Shares | 0 | 119 | 101 | 91 | 78 |
| Retained earnings | -103,858 | -100,031 | -95,964 | -89,135 | -84,692 |
| Other shareholders' equity | -22 | -14 | -5 | 2 | 1 |
| TOTAL | $5,089 | $5,040 | $5,769 | $8,087 | $6,523 |
| Total Liabilities And Equity | $6,167 | $5,782 | $6,413 | $8,667 | $7,160 |